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Five human coronaviruses (HCoVs) have been iden-
tified to date. HCoV-OC43 and HCoV-229E were first 
identified in the mid-1960s (Hamre & Procknow 1966) 
and were subsequently found to cause the common cold. 
These viruses were the only coronaviruses identified in 
humans until 2003, when HCoVs received worldwide at-
tention with the emergence of severe acute respiratory 
syndrome (SARS), which is caused by a novel corona-
virus (SARS-CoV). The increased research on these 
viruses led to the discovery of two additional HCoVs: 
HCoV-NL63 in the Netherlands and HCoV-HKU1 
in China (van der Hoek et al. 2004, Woo et al. 2005). 
HCoVs cause upper respiratory tract illness and occa-
sionally cause lower respiratory tract disease in suscep-
tible individuals. The incidence and clinical features of 
HCoV infections in Brazilian patients with respiratory 
illness is not well known, especially among adults. There 
are few studies that describe HCoV infections among 
adults (Bellei et al. 2008, Gaunt et al. 2010). The aim 
of the present study was to investigate the occurrence 
of HCoVs among Brazilian outpatients and hospitalised 
patients who received care at the Hospital of São Paulo 
Federal University, Brazil, during 2009 and 2010. A to-
tal of 394 samples were collected with nasopharyngeal 
swabs. The final pool of subjects included 182 outpatient 
children from the general community and 212 hospita-
lised patients; of these 212 patients, 136 were children 
and 76 were adults. Assays to identify HCoVs in patients 
were performed using a two-step process. First, an initial 
pancoronavirus reverse-transcription polymerase chain 
reaction (RT-PCR) screening assay was performed (Vi-
jgen et al. 2008). Second, species-specific RT-PCR as-
says were used to identify the specific HCoV species 
(Dare et al. 2007). Amplicons were further character-
ised by sequencing. Epidemiological and clinical data 
from outpatients were obtained using a standardised 
questionnaire and data from hospitalised patients were 
obtained from medical charts. The pancoronavirus assay 
detected five/394 (1.2%) coronavirus-positive samples. 
Within the outpatient group, which was comprised only 
children, one/182 (0.5%) patients was positive. Within 
the hospitalised patient group, four/212 (1.8%) patients 
were positive: two/136 were children (1.4%) and two/76 
were adults (2.6%). HCoV-OC43 was documented in two 
samples from hospitalised patients, one of which was a 
nosocomial infection; three HCoV-NL63 positive sam-
ples were identified, one of which was obtained from an 
outpatient and two of which were obtained from hospi-
talised patients. Sequencing confirmed the specificity 
of the species-specific RT-PCR assays. Coronavirus in-
fections occurred during the spring, autumn and winter 
and more coronavirus-infected cases were documented 
in 2010 than in 2009. The median age of HCoV-infected 
patients was seven years (ranging from 11 months to 46 
years). Eighty percent (4/5) of infected patients report-
ed several underlying conditions, but no chronic lung 
disease was reported (Table). Fever and cough were the 
most common symptoms at presentation. Dyspnea was 
reported in two cases and bronchospasm was only re-
ported in the three HCoV-NL63 cases. Three patients 
presented with lower respiratory tract infections. Two 
of the hospitalised patients were further admitted to the 
intensive care unit during their hospital stay. Eight days 
was the median length of the hospital stay for hospita-
lised coronavirus-infected patients (ranging from 5-30 
days). HCoV-OC43-infected patients had longer hospital 
stays than HCoV-NL63-infected patients. Three of the 
four hospitalised patients had good outcomes, but the 
diabetic adult died of HCoV-NL63-associated pneumo-
nia nine days after admission. The present study is the 
first Brazilian report of HCoV infections in outpatients 
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and hospitalised patients to describe NL63 infection in 
an adult patient. Because the subjects of our study in-
cluded both outpatients and hospitalised patients, the 
majority of the patients included in this study were be-
lieved to have a common cold. The composition of our 
subject pool could be a limitation of our study and might 
explain the small number of coronavirus-positive cases. 
Gaunt et al. (2010) detected 0.3-0.85% coronavirus-pos-
itive samples across all ages and we hypothesised that 
the H1N1 2009 influenza pandemic wave might have 
influenced the dynamics of the other respiratory virus-
es, mainly in 2009. The coronavirus-positive rate found 
among adults revealed that HCoVs may be representa-
tive causal agents of respiratory disease among adults as 
well as children. This study is one of the few studies to 
record a fatal case of HCoV-NL63 infection (Bastien et 
al. 2005, Cabeça & Bellei 2012). In conclusion, our data 
demonstrate that HCoVs can cause more than just the 
common cold and mild respiratory tract disease. There-
fore, at-risk patients presenting with severe respiratory 
infections should be evaluated for HCoV infections. Ac-
cording to the data presented herein, the NL63 HCoV 
represents an important pathogen that is involved in un-
explained respiratory illnesses.
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TABLE
Demographic and clinical data of coronavirus-infected patients during 2009-2010
Patients
1 2 3 4 5
Characteristics
HCoV species HCoV-OC43 HCoV-NL63 HCoV-OC43 HCoV-NL63 HCoV-NL63
Sample date September/09 May/10 April/10 June/10 June/10
Age 2 years 5 years 43 years 46 years 11 months
Gender Female Female Male Female Female
Underlying Megacolon None HIV Diabetes Liver
Disease Prematurity - - Mellitus Transplant
History of smoking - - + + -
Clinical features
Fever + + + + +
Cough + + + + +
Myalgia - + + + -
Headache - - + - -
Diarrhoea - - - + -
Rhinorrhoea - + - + -
Sore throat - - - + -
Bronchospasm - - - + -
Dyspnea - - + + -
LRTI + - + + -
Hospitalization + - + + +
Outcome Survived Survived Survived Died Survived
HCoV: human coronaviruses; LRTI: lower respiratory tract illness; HIV: human immunodeficiency virus infected; +: present; 
-: absent.
